^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
inixaciclib (NUV-422)
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Nuvation Bio
Drug class:
CDK4 inhibitor, CDK6 inhibitor, CDK2 inhibitor
Related drugs:
Phase 1/2
Nuvation Bio Inc.
Withdrawn
Last update posted :
07/11/2023
Initiation :
09/01/2022
Primary completion :
06/01/2025
Completion :
09/01/2026
HER-2
|
HER-2 negative
|
fulvestrant • inixaciclib (NUV-422)
Share
